AV9: TIVOZANIB
AV9 is a Ligand Of Interest in 8BEM designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 8BEM_AV9_B_401 | 71% | 47% | 0.104 | 0.928 | 0.89 | 1.06 | 2 | 4 | 0 | 0 | 100% | 1 |
| 8BEM_AV9_D_401 | 64% | 50% | 0.111 | 0.912 | 0.91 | 0.9 | 2 | 3 | 2 | 0 | 100% | 1 |
| 8BEM_AV9_A_401 | 60% | 50% | 0.12 | 0.905 | 0.86 | 0.96 | 1 | 3 | 3 | 0 | 100% | 1 |
| 8BEM_AV9_G_401 | 48% | 52% | 0.141 | 0.882 | 0.8 | 0.92 | 2 | 2 | 3 | 0 | 100% | 1 |
| 4ASE_AV9_A_3169 | 82% | 26% | 0.078 | 0.938 | 1.78 | 1.13 | 9 | 2 | 1 | 0 | 100% | 1 |